1. The Mycotoxin Beauvericin Exhibits Immunostimulatory Effects on Dendritic Cells
- Author
-
Xiaoli, Yang, Shafaqat, Ali, Manman, Zhao, Lisa, Richter, Vanessa, Schäfer, Julian, Schliehe-Diecks, Marian, Frank, Jing, Qi, Pia-Katharina, Larsen, Jennifer, Skerra, Heba, Islam, Thorsten, Wachtmeister, Christina, Alter, Anfei, Huang, Sanil, Bhatia, Karl, Köhrer, Carsten, Kirschning, Heike, Weighardt, Ulrich, Kalinke, Rainer, Kalscheuer, Markus, Uhrberg, and Stefanie, Scheu
- Subjects
Toll-Like Receptor 4 ,Adaptor Proteins, Vesicular Transport ,Mice ,HEK293 Cells ,Depsipeptides ,Myeloid Differentiation Factor 88 ,Animals ,Cytokines ,Humans ,Dendritic Cells ,Mycotoxins ,Interleukin-12 ,Signal Transduction - Abstract
Beauvericin (BEA), a mycotoxin of the enniatin family produced by various toxigenic fungi, has been attributed multiple biological activities such as anti-cancer, anti-inflammatory, and anti-microbial functions. However, effects of BEA on dendritic cells remain unknown so far. Here, we identified effects of BEA on murine granulocyte-macrophage colony-stimulating factor (GM-CSF)-cultured bone marrow derived dendritic cells (BMDCs) and the underlying molecular mechanisms. BEA potently activates BMDCs as signified by elevated IL-12 and CD86 expression. Multiplex immunoassays performed on myeloid differentiation primary response 88 (MyD88) and toll/interleukin-1 receptor (TIR) domain containing adaptor inducing interferon beta (TRIF) single or double deficient BMDCs indicate that BEA induces inflammatory cytokine and chemokine production in a MyD88/TRIF dependent manner. Furthermore, we found that BEA was not able to induce IL-12 or IFNβ production in Toll-like receptor 4 (
- Published
- 2022